Stem cell therapies for muscle disorders.

PURPOSE OF REVIEW This review focuses on stem cell-based therapies to treat skeletal muscle disorders, with a special emphasis on muscular dystrophies. RECENT FINDINGS We briefly review previous attempts at cell therapy by the use of donor myoblasts, explaining the likely reasons for the poor clinical results; we then describe the use of the same cells in current promising trials for localized treatments of different diseases of skeletal muscle. Moreover, we discuss important novel findings on muscle stem/progenitor cell biology and their promise for future clinical translation. Preclinical and clinical applications of novel myogenic stem/progenitor cells are also described. SUMMARY We summarize several ongoing clinical trials for different muscle disorders and the advances in the understanding of the biology of the myogenic progenitors used in such trials. On the basis of the currently available information, a prediction of developments in the field is proposed.

[1]  M. Oshimura,et al.  Complete Genetic Correction of iPS Cells From Duchenne Muscular Dystrophy , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[2]  Valentina Proserpio,et al.  TNF/p38α/polycomb signaling to Pax7 locus in satellite cells links inflammation to the epigenetic control of muscle regeneration. , 2010, Cell stem cell.

[3]  Yu Xin Wang,et al.  Satellite cells, the engines of muscle repair , 2011, Nature Reviews Molecular Cell Biology.

[4]  J. Statland,et al.  Facioscapulohumeral muscular dystrophy: molecular pathological advances and future directions. , 2011, Current opinion in neurology.

[5]  R. Horch,et al.  Engineering skeletal muscle tissue – new perspectives in vitro and in vivo , 2010, Journal of cellular and molecular medicine.

[6]  W. Schwaiger,et al.  Muscle-derived cell injection to treat anal incontinence due to obstetric trauma: pilot study with 1 year follow-up , 2009, Gut.

[7]  M. Baiocchi,et al.  The meso-angioblast: a multipotent, self-renewing cell that originates from the dorsal aorta and differentiates into most mesodermal tissues. , 2002, Development.

[8]  Shinya Yamanaka,et al.  A Fresh Look at iPS Cells , 2009, Cell.

[9]  Jennifer A. Lawson,et al.  Satellite cells , connective tissue fibroblasts and their interactions are crucial for muscle regeneration , 2022 .

[10]  M. Fiszman,et al.  Systemic delivery of allogenic muscle stem cells induces long-term muscle repair and clinical efficacy in duchenne muscular dystrophy dogs. , 2011, The American journal of pathology.

[11]  R. Storb,et al.  Hematopoietic cell transplantation: five decades of progress. , 2003, Archives of medical research.

[12]  Tom H. Cheung,et al.  Maintenance of muscle stem cell quiescence by microRNA-489 , 2012, Nature.

[13]  M. Kyba,et al.  Assessment of the Myogenic Stem Cell Compartment Following Transplantation of Pax3/Pax7‐Induced Embryonic Stem Cell‐Derived Progenitors , 2011, Stem cells.

[14]  K. Hochedlinger,et al.  Guidelines and techniques for the generation of induced pluripotent stem cells. , 2008, Cell stem cell.

[15]  Kenneth R Chien,et al.  Towards regenerative therapy for cardiac disease , 2012, The Lancet.

[16]  Y. Torrente,et al.  Partial dysferlin reconstitution by adult murine mesoangioblasts is sufficient for full functional recovery in a murine model of dysferlinopathy , 2010, Cell Death and Disease.

[17]  N. Ip,et al.  Erratum: Cdk5-mediated phosphorylation of endophilin B1 is required for induced autophagy in models of Parkinson's disease (Nature Cell Biology (2011) 13 (568-579)) , 2011 .

[18]  G Cossu,et al.  Muscle regeneration by bone marrow-derived myogenic progenitors. , 1998, Science.

[19]  Michelle Bradbury,et al.  Derivation of engraftable skeletal myoblasts from human embryonic stem cells , 2007, Nature Medicine.

[20]  Hiroshi Yamamoto,et al.  Generation of transplantable, functional satellite‐like cells from mouse embryonic stem cells , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  M. Blasco,et al.  A Subpopulation of Adult Skeletal Muscle Stem Cells Retains All Template DNA Strands after Cell Division , 2012, Cell.

[22]  D. Wells,et al.  Restoration of dystrophin expression using the Sleeping Beauty transposon , 2011, PLoS currents.

[23]  A. Emery,et al.  The muscular dystrophies , 2002, The Lancet.

[24]  Giulio Cossu,et al.  Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs , 2006, Nature.

[25]  E. Chaney,et al.  Multipotential mesoangioblast stem cell therapy in the mdx/utrn-/- mouse model for Duchenne muscular dystrophy. , 2007, Regenerative medicine.

[26]  Francesco Muntoni,et al.  Dystrophin and mutations: one gene, several proteins, multiple phenotypes , 2003, The Lancet Neurology.

[27]  H. Blau,et al.  Self-renewal and expansion of single transplanted muscle stem cells , 2008, Nature.

[28]  Michael Kyba,et al.  Functional skeletal muscle regeneration from differentiating embryonic stem cells , 2008, Nature Medicine.

[29]  D. Castel,et al.  A Critical Requirement for Notch Signaling in Maintenance of the Quiescent Skeletal Muscle Stem Cell State , 2012, Stem cells.

[30]  M. Kyba,et al.  Human ES- and iPS-derived myogenic progenitors restore DYSTROPHIN and improve contractility upon transplantation in dystrophic mice. , 2012, Cell stem cell.

[31]  S. Tapscott,et al.  Cell-lineage regulated myogenesis for dystrophin replacement: a novel therapeutic approach for treatment of muscular dystrophy. , 2008, Human molecular genetics.

[32]  S. Tapscott,et al.  Hematopoietic Cell Transplantation Provides an Immune-tolerant Platform for Myoblast Transplantation in Dystrophic Dogs , 2008, Molecular Therapy.

[33]  G. Butler-Browne,et al.  Replicative potential and telomere length in human skeletal muscle: implications for satellite cell-mediated gene therapy. , 1997, Human gene therapy.

[34]  J. Mendell,et al.  Dystrophin immunity in Duchenne's muscular dystrophy. , 2010, The New England journal of medicine.

[35]  M. Sampaolesi,et al.  New therapies for Duchenne muscular dystrophy: challenges, prospects and clinical trials. , 2007, Trends in molecular medicine.

[36]  G. Floris,et al.  Intrinsic cell memory reinforces myogenic commitment of pericyte‐derived iPSCs , 2011, The Journal of pathology.

[37]  M. Oshimura,et al.  Transplantation of Genetically Corrected Human iPSC-Derived Progenitors in Mice with Limb-Girdle Muscular Dystrophy , 2012, Science Translational Medicine.

[38]  S. Delp,et al.  Short Telomeres and Stem Cell Exhaustion Model Duchenne Muscular Dystrophy in mdx/mTR Mice , 2010, Cell.

[39]  B. Sacchetti,et al.  Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells , 2007, Nature Cell Biology.

[40]  K. Isobe,et al.  Paraxial Mesodermal Progenitors Derived from Mouse Embryonic Stem Cells Contribute to Muscle Regeneration via Differentiation into Muscle Satellite Cells , 2008, Stem cells.

[41]  M. Oshimura,et al.  Stem Cell–Mediated Transfer of a Human Artificial Chromosome Ameliorates Muscular Dystrophy , 2011, Science Translational Medicine.

[42]  S. Thrun,et al.  Substrate Elasticity Regulates Skeletal Muscle Stem Cell Self-Renewal in Culture , 2010, Science.

[43]  D. Sassoon,et al.  Identification and characterization of a non-satellite cell muscle resident progenitor during postnatal development , 2010, Nature Cell Biology.

[44]  Beatrice Bodega,et al.  A Long ncRNA Links Copy Number Variation to a Polycomb/Trithorax Epigenetic Switch in FSHD Muscular Dystrophy , 2012, Cell.

[45]  R. Benezra,et al.  Slow-dividing satellite cells retain long-term self-renewal ability in adult muscle , 2012, Journal of Cell Science.

[46]  C. Siu,et al.  Functional Mesenchymal Stem Cells Derived From Human Induced Pluripotent Stem Cells Attenuate Limb Ischemia in Mice , 2010, Circulation.

[47]  K. Mamchaoui,et al.  Premature proliferative arrest of cricopharyngeal myoblasts in oculo-pharyngeal muscular dystrophy: Therapeutic perspectives of autologous myoblast transplantation , 2006, Neuromuscular Disorders.

[48]  M. Kyba,et al.  Functional Myogenic Engraftment from Mouse iPS Cells , 2011, Stem Cell Reviews and Reports.

[49]  L. Kunkel,et al.  Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts , 1989, Nature.

[50]  Concepcion R. Nierras,et al.  The promise of human induced pluripotent stem cells for research and therapy , 2008, Nature Reviews Molecular Cell Biology.

[51]  Charlotte Collins,et al.  Direct Isolation of Satellite Cells for Skeletal Muscle Regeneration , 2005, Science.

[52]  M. G. Cusella De Angelis,et al.  High efficiency myogenic conversion of human fibroblasts by adenoviral vector-mediated MyoD gene transfer. An alternative strategy for ex vivo gene therapy of primary myopathies. , 1998, The Journal of clinical investigation.

[53]  Christoph Lepper,et al.  An absolute requirement for Pax7-positive satellite cells in acute injury-induced skeletal muscle regeneration , 2011, Development.

[54]  S. Antonini,et al.  Pericytes resident in postnatal skeletal muscle differentiate into muscle fibres and generate satellite cells. , 2011, Nature communications.

[55]  Tom H. Cheung,et al.  Alternative polyadenylation mediates microRNA regulation of muscle stem cell function. , 2012, Cell stem cell.

[56]  Tom H. Cheung,et al.  Notch Signaling Is Necessary to Maintain Quiescence in Adult Muscle Stem Cells , 2012, Stem cells.

[57]  A. Wagers,et al.  Highly Efficient, Functional Engraftment of Skeletal Muscle Stem Cells in Dystrophic Muscles , 2008, Cell.

[58]  T. Partridge.  Impending therapies for Duchenne muscular dystrophy. , 2011, Current opinion in neurology.

[59]  J. Itskovitz‐Eldor,et al.  Multipotent Vasculogenic Pericytes from Human Pluripotent Stem Cells Promote Recovery of Murine Ischemic Limb Running title: Dar et al.; Human pluripotent stem cell-derived pericytes , 2011 .

[60]  A. Mauro.  SATELLITE CELL OF SKELETAL MUSCLE FIBERS , 1961, The Journal of biophysical and biochemical cytology.

[61]  K. Davies,et al.  Molecular mechanisms of muscular dystrophies: old and new players , 2006, Nature Reviews Molecular Cell Biology.

[62]  M. Chancellor,et al.  Development of cellular therapy for the treatment of stress urinary incontinence , 2011, International Urogynecology Journal.

[63]  B. Malissen,et al.  Pax7-expressing satellite cells are indispensable for adult skeletal muscle regeneration , 2011, Development.

[64]  T. Rando,et al.  Emerging models and paradigms for stem cell ageing , 2011, Nature Cell Biology.

[65]  S. Yamanaka,et al.  Generation of skeletal muscle stem/progenitor cells from murine induced pluripotent stem cells , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[66]  R. Cooper,et al.  Reversible immortalization of human myogenic cells by site-specific excision of a retrovirally transferred oncogene. , 1999, Human gene therapy.

[67]  G. Pellegrini,et al.  Regeneration of squamous epithelia from stem cells of cultured grafts. , 2006, Regenerative medicine.

[68]  N. Bresolin,et al.  Cell Therapy of α-Sarcoglycan Null Dystrophic Mice Through Intra-Arterial Delivery of Mesoangioblasts , 2003, Science.

[69]  D. Cacchiarelli,et al.  A Long Noncoding RNA Controls Muscle Differentiation by Functioning as a Competing Endogenous RNA , 2011, Cell.

[70]  J. Tremblay,et al.  Past, present and future of myoblast transplantation in the treatment of Duchenne muscular dystrophy , 2010, Pediatric transplantation.

[71]  M. Sampaolesi,et al.  Alpha sarcoglycan is required for FGF-dependent myogenic progenitor cell proliferation in vitro and in vivo , 2011, Development.

[72]  G. Cossu,et al.  Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells. , 2010, The Journal of clinical investigation.

[73]  M. Chancellor,et al.  Muscle derived stem cell therapy for stress urinary incontinence , 2008, World Journal of Urology.